A detailed history of Arnhold LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Arnhold LLC holds 8,942 shares of MRK stock, worth $1.14 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
8,942
Previous 8,942 -0.0%
Holding current value
$1.14 Million
Previous $974,000 21.05%
% of portfolio
0.13%
Previous 0.11%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

BUY
$102.95 - $114.33 $20,590 - $22,866
200 Added 2.29%
8,942 $920,000
Q4 2022

Feb 07, 2023

SELL
$87.44 - $112.11 $256,548 - $328,930
-2,934 Reduced 25.13%
8,742 $969,000
Q2 2022

Jul 26, 2022

BUY
$83.49 - $94.64 $244,959 - $277,673
2,934 Added 33.56%
11,676 $1.07 Million
Q1 2022

May 10, 2022

BUY
$73.51 - $82.4 $7,351 - $8,240
100 Added 1.16%
8,742 $717,000
Q4 2021

Feb 08, 2022

SELL
$72.28 - $90.54 $11.1 Million - $14 Million
-154,134 Reduced 94.69%
8,642 $662,000
Q3 2021

Oct 19, 2021

SELL
$71.68 - $78.83 $95,979 - $105,553
-1,339 Reduced 0.82%
162,776 $12.2 Million
Q2 2021

Aug 04, 2021

BUY
$70.31 - $77.77 $1.31 Million - $1.45 Million
18,642 Added 12.81%
164,115 $12.8 Million
Q1 2021

Apr 30, 2021

BUY
$68.86 - $81.11 $8.91 Million - $10.5 Million
129,431 Added 806.83%
145,473 $11.2 Million
Q4 2019

Feb 05, 2020

SELL
$77.58 - $87.54 $1.19 Million - $1.34 Million
-15,312 Reduced 48.84%
16,042 $1.46 Million
Q2 2019

Aug 08, 2019

SELL
$69.84 - $81.59 $65,370 - $76,368
-936 Reduced 2.9%
31,354 $2.63 Million
Q1 2019

May 09, 2019

SELL
$69.58 - $79.36 $1.77 Million - $2.02 Million
-25,500 Reduced 44.13%
32,290 $2.69 Million
Q1 2018

May 11, 2018

BUY
$50.96 - $59.23 $2.94 Million - $3.42 Million
57,790 New
57,790 $3.15 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Arnhold LLC Portfolio

Follow Arnhold LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arnhold LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arnhold LLC with notifications on news.